Brief: AVITA Medical Submits FDA Pma Application To Expand Indication To Vitiligo
19/12/2022 13:06
Dec 19 (Reuters) - AVITA Medical Inc RCEL.O :
* AVITA MEDICAL SUBMITS FDA PMA APPLICATION TO EXPAND
INDICATION
TO VITILIGO
Source text for Eikon: ID:nGNX9cGRDq
Further company coverage: RCEL.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on AVITA Medical
See all newsAvita Medical Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Avita Medical Inc Expected To Post A Loss Of 29 Cents A Share: Earnings Preview
Brief: AVITA Medical Q1 EPS USD -0.35
Brief: AVITA Medical Q4 EPS USD -0.38
Brief: Avita Medical Inc - Enters Into Credit Agreement And Guaranty - SEC Filing